NCT04574128Unknown不适用
Blood Loss With Cardiopulmonary Bypass, Re-transfusion or Not.
Örebro University, Sweden2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年10月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- blood loss
研究概览
简要总结
This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Sequential
- 主要目的
- Treatment
- 盲法
- Double (Participant, Care Provider)
盲法说明
The person that controle the heart- and lung mashine is not masked. Other members of the surgical team is masked.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Elective CABG.
排除标准
- •Anaemia, infection, massive bleeding, CABG off pump.
结局指标
主要结局
blood loss
时间窗: During 5 days hemoglobin will be measured as the clinical rutine or as needed.
Hemoglobin
Blood loss
时间窗: During 2 days or while surgical drains remains, blood volume in mL is measured.
Blood volume in millilitre (mL)
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
不适用
Cell Salvage During Caesarean Section (CSCS)Blood TransfusionNCT03429790Wenzhou Medical University120
尚未招募
不适用
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk UreteroscopyInfections, Urinary TractNephrolithiasisNCT06149455University of California, San Francisco72
已完成
3 期
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in AdultsCovid19NCT04617483Sinovac Research and Development Co., Ltd.1,040
撤回
不适用
Transfusion Requirements After Orthotopic Liver TransplantationAnemiaNCT01435746University Medical Center Goettingen
已完成
不适用
Drainage Amount for Removal of Thoracostomy TubePneumothoraxPleural EffusionNCT00575198University of California, Davis280